Ophthalmic Clinical Education Summit

August 11-27, 2020

Welcome to the first Ophthalmic Clinical Education Summit!

We are excited to welcome you to this unique educational event brought to you by ZEISS. This virtual meeting will span over three weeks with 3-day tracks for each specialty in Retina, Glaucoma and Surgical. Learn from the experts and from your peers’ personal experience how to get the most out of ZEISS solutions.

The agenda is jam-packed with tips, techniques and practical information you can walk away with and begin using immediately as part of your daily routine. Take a look at the program, roughly four hours per week per specialty area, and register* for all sessions of your choice.

Enjoy the opportunity to ask your colleagues and ZEISS experts questions and share feedback about our technology.

We look forward to seeing you online!

Dr. John Hovanesian, Dr. Rick Lewis and Dr. Rishi Singh
Program Moderators

* Participants are required to register separately for each individual session. This online education program (courses/sessions) is not CME/COPE approved.

John Hovanesian, MD
John Hovanesian, MD
Rishi Singh, MD
Rishi Singh, MD
Rick Lewis, MD
Rick Lewis, MD

Keynote Speakers

Phil Rosenfeld, MD, PhD
AUG 11 – Opening keynote address by

Phil Rosenfeld, MD, PhD

Evolving Clinical Impact of SS-OCT-Angiography

This event has concluded.

Jeff Goldberg, MD, PhD
AUG 25 – Closing keynote address by

Jeffrey Goldberg, MD, PhD

Incorporating Advanced Technology and Protocols for Glaucoma Management

Week 1

This programming week has concluded.


Week 2

SURGICAL PART 2:

Practical Application of Modern Biometry

Tuesday, August 18, 2020, 7:00-8:00pm EST / 8:00-9:00am JST (Aug. 12)

Agenda: Preoperative measurements for cataract and LASIK procedures, the science behind modern optical biometry, IOLM printout interpretation, ideal scans for optimized outcomes, corneal topography, the line between regular and irregular corneas, dry eye, Q&A and more.

Speaker details

John Hovanesian, MD

John Hovanesian, MD (Moderator)

Harvard Eye Associates
Laguna Hills, CA

Sumitra Khandelwal, MD

Sumitra Khandelwal, MD

Baylor College of Medicine
Houston, TX

Daniel Chang. MD

Daniel Chang, MD

Empire Eye & Laser Center
Bakersfield, CA

GLAUCOMA PART 2:

A Focus on VF and Imaging

Wednesday, August 19, 2020, 7:00-8:30pm EST / 8:00-9:30am JST (Aug. 20)

Agenda: Consensus guidelines and current protocols with COVID, ultra-widefield vs. traditional fundus imaging, MD VF interpretation, guided progression analysis, case-based grand rounds (the marriage of fundus and VF) and the future of VF

Speaker details

Rick Lewis, MD

Rick Lewis, MD (Moderator) Sacramento Eye Consultants
Sacramento, CA

Michael Chaglasian, OD, FAAO

Michael Chaglasian
OD, FAAO

Illinois Eye Institute
Illinois College of Optometry
Chicago, IL

Shalini Sood-Mendiratta, MD

Shalini
Sood-Mendiratta, MD

Cole Eye Institute
Cleveland Clinic
Cleveland, OH

RETINA PART 2:

A Focus on Widefield Fundus Imaging

Thursday, August 20, 2020, 7:00-8:30pm EST / 8:00-9:30am JST (Aug. 21)

Agenda: Imaging for retinal diseases using UWF (color, FAF, FA, ICGA), diagnostic case-based examples, case-based grand rounds (AMD/PCV, DR and vascular diseases, tumors), the future of retinal imaging and Q&A.

Speaker details

Rishi Singh, MD

Rishi Singh, MD (Moderator)

Cole Eye Institute
Cleveland Clinic
Cleveland, OH

Miguel Materin, MD

Miguel Materin, MD

Duke University Eye Center
Durham, NC

Sarah Read, MD

Sarah Read, MD, PhD

Retina Consultants of Hawai'i
University of Hawai'i
John A. Burns School of Medicine
Honolulu, HI

Week 3

GLAUCOMA PART 3:

Putting It All Together Using Image Management Solutions

Tuesday, August 25, 2020, 7:00-8:30pm EST / 8:00-9:30am JST (Aug. 26)

Agenda: An interactive overview of the Glaucoma Workplace, a case-based discussion using GWP, combining VF/Fundus imaging, OCT, structure and function, closing keynote address by Dr. Jeff Goldberg, the future landscape of telemedicine, Q&A and more.

Speaker details

Jeff Goldberg, MD, PhD

Jeffrey Goldberg, MD, PhD (Keynote)

Byers Eye Institute
Stanford University
Palo Alto, CA

Rick Lewis, MD

Rick Lewis, MD (Moderator) Sacramento Eye Consultants
Sacramento, CA

Lama Al-Aswad, MD

Lama Al-Aswad, MD, MPH

NYU Langone Eye Center
New York, NY

Jennifer Gould, OD

Jennifer Gould, OD, MS, FAAO, Dipl ABO

SUNY College of Optometry
New York, NY

RETINA PART 3:

Putting It All Together Using Image Management Solutions

Wednesday, August 26, 2020, 7:00-8:30pm EST / 8:00-9:30am JST (Aug. 27)

Agenda: An interactive overview of the Retina Workplace, overview of RWP vs. FORUM, combining fundus imaging/OCT/OCTA, baselining and surgical decision making, EMR integration and challenges, RWP and diagnostics, the longitudinal patient perspective, the future of patient management and new protocols, discussion, Q&A and more.

Speaker details

Rishi Singh, MD

Rishi Singh, MD (Moderator)

Cole Eye Institute
Cleveland Clinic
Cleveland, OH

Eric Schneider, MD

Eric Schneider, MD

Tennessee Retina Physicians
Nashville, TN

SURGICAL PART 3:

Optimizing the Microscope for Ideal Outcomes

Thursday, August 27, 2020, 7:00-8:00pm EST / 8:00-9:00am JST (Aug. 28)

Agenda: How to optimize your microscope for anterior, retina and glaucoma applications, patient set-up and preparation for cataract procedures, the importance of intraoperative OCT, plus real-world iOCT in cataract and retina surgery.

Speaker details

John Hovanesian, MD

John Hovanesian, MD (Moderator)

Harvard Eye Associates
Laguna Hills, CA

Ashleigh Levinson, MD

Ashleigh Levison, MD

Colorado Retina Associates
Denver, CO

Julie Schallhorn, MD

Julie Schallhorn, MD, MS

UCSF School of Medicine
San Francisco, CA

About the Speakers

Click below to read more about our distinguished moderators, keynote speakers and panelists.

Keynote Speakers

Closing Keynote / Glaucoma Track
Dr. Jeffrey Goldberg
is Professor and Chair of Ophthalmology at the Byers Eye Institute at Stanford University. His clinical effort is focused on patients in need of medical or surgical intervention for glaucoma and other retinal and optic nerve diseases, as well as cataract. His research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his laboratory is developing novel stem cell and nanotherapeutics approaches for eye repair.

Opening Keynote / Retina Track
Dr. Phil Rosenfeld
, Professor of Ophthalmology at the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, is a vitreoretinal specialist with a primary clinical research interest in age-related macular degeneration (AMD). His major contributions include the clinical development of anti-VEGF therapies, the use of optical coherence tomography (OCT) guided treatment using anti-VEGF therapy, the clinical development of OCT instruments, and the development and use of novel OCT algorithms for the diagnosis and management of macular diseases and for use as clinical trial endpoints.

Session Moderators

Surgical Track
John Hovanesian, MD
is a board-certified ophthalmologist, a faculty member at the UCLA Stein Eye Institute, and an internationally recognized leader in the fields of corneal, cataract, refractive, and laser surgery. He has published two eye surgery textbooks - one on the subject of refractive cataract surgery, and one on pterygium surgery. He received his medical degree from the University of Michigan Medical School and completed his residency at Henry Ford Hospital in Detroit, where he was selected to serve as Chief Resident. He also completed a two-year fellowship in refractive and corneal surgery at the Jules Stein Eye Institute at UCLA. He joined Harvard Eye Associates in 1999.

Glaucoma Track
Richard A. Lewis, MD
is the former director of glaucoma at the University of California, Davis. In 1988, he co-founded Sacramento Eye Consultants in Sacramento, CA. In addition to his busy clinical practice, Dr. Lewis is actively involved in clinical research in national and international trials in anterior segment disease and glaucoma therapy. He is the past President of the American Society of Cataract and Refractive Surgery (2014-15) and past President of the American Glaucoma Society (2000-02). Dr. Lewis is the medical Editor Emeritus of Glaucoma Today and on the editorial board of the Journal of Cataract and Refractive Surgery, Journal of Glaucoma, Advanced Ocular Care, Glaucoma Physician and Ocular Surgery News. He is co-founder of Sacramento’s Capital City Surgery Center (2003) and the current Chief Medical Officer for Aerie Pharmaceuticals (2015).

Retina Track
Rishi P. Singh MD
is a staff surgeon at the Cole Eye Institute, Cleveland Clinic and Associate Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored more than 140 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. Dr. Singh is the former president on the Retina World Congress and is on the board of the American Society of Retina Specialists.

Distinguished Panelists

Retina Track

Mark Dunbar, OD, FAAO
, graduated from the Michigan College of Optometry at Ferris State University in 1986 and went on to complete a Fellowship in Ocular Disease at the Omni Eye Services of Lexington, Kentucky. He has been on staff at the University of Miami’s Bascom Palmer Eye Institute for over 30 years and currently serves as Director of Optometric Services. Dr. Dunbar is a Fellow of the American Academy of Optometry and a founding member of the Optometric Glaucoma Society and the Optometric Retina Society. He also serves on the Editorial Board for Review of Optometry.

Miguel Materin, MD, is a Professor of Ophthalmology and Professor of Radiation Oncology, at Duke University. Director of the Center for Ocular Oncology at Duke. Joined Duke in 2016. He did his Fellowship in Ocular Oncology at Wills Eye Hospital 1999, then joined the practice and worked for 7 years (2002-2009). Dr. Materin was also the Director of Ocular Oncology at Smilow Cancer at Yale University (2009-2016).

Aleksandra V. Rachitskaya, MD, is an Assistant Professor in the Department of Ophthalmology at Case Western Reserve University’s Cleveland Clinic Lerner College of Medicine and a member of the vitreoretinal faculty at Cleveland Clinic’s Cole Eye Institute. She specializes in the diagnosis and management of medical and surgical retinal diseases. Prior to her appointment at the Cleveland Clinic in 2014, Dr. Rachitskaya served on faculty of the Bascom Palmer Eye Institute in Miami, Florida, as the Chief Resident and Director of Ocular Trauma.

Sarah Read, MD, PhD, is a clinical educator at the University of Hawai'i, John A. Burns School of Medicine and practicing physician at Retina Consultants of Hawai'i. She received her MD from Tufts University. While at Tufts University, Dr. Read completed a PhD sponsored by the National Institute of Health developing novel gene therapies in the treatment of retinal disease. She completed her ophthalmology residency at the Bascom Palmer Eye Institute in Miami, Florida. As Chief Resident, Dr. Read completed a Vitreoretinal fellowship and then served as Director of Ocular Trauma and Chief of Services for the residency program.

Eric Schneider, MD is a retina specialist and partner at Tennessee Retina PC in Nashville, Tennessee. He completed his medical school and ophthalmology residency at the University of Michigan Medical School and completed his fellowship in vitreoretinal surgery at Duke University. His research focuses on treatment of refractory age-related macular degeneration, diabetic retinopathy, vitreoretinal interface disease, and novel OCT applications including OCT angiography. He has authored or co-authored over 25 peer reviewed articles and book chapters and served as an investigator in numerous clinical trials.  


Glaucoma Track

Lama A. Al-Aswad, MD, MPH, is ophthalmologist with subspecialty in glaucoma and cataract with a strong interest in disease prevention and population health management. She is professor of ophthalmology at NYU Langone Health and the Vice Chair for Innovations and the Director of Teleophthalmology, Artificial Intelligence and Innovations and the Associate director of the glaucoma fellowship. Dr. Al-Aswad is a believer in prevention of blindness as evident from her large-scale glaucoma screening project in NYC where she screened more than 8500 individuals for glaucoma. In 2019, she piloted the first teleophthalmology kiosk for screening for the four leading causes of blindness. Dr. Al-Aswad has experience in building data capturing systems in addition to app development. She is currently working on validating artificial intelligence systems in glaucoma and diabetic retinopathy screening as a tool in blindness prevention.

Michael Chaglasian, OD, FAAO, is an Associate Professor at the Illinois College of Optometry and Chief of Staff of the Illinois Eye Institute. He is a graduate of State University of New York College of Optometry and completed a Residency in Primary Eye Care/Ocular Disease at the Pennsylvania College of Optometry. Dr. Chaglasian is charge of the Glaucoma Service at the Illinois Eye Institute, providing patient care while instructing residents and students. His clinical practice is directed exclusively to patients with glaucoma while co-managing surgical care with two glaucoma specialists. His research interests include normal tension glaucoma, automated perimetry and the clinical use of OCT imaging. 

Jennifer Gould, MD, MS, FAAO, Dipl ABO, is an Associate Clinical Professor at SUNY College of Optometry and the Chief of Advanced Care Services for the University Eye Center. She earned both her Doctor of Optometry and Masters of Vision Science degrees from SUNY Optometry in 2013. She completed an ocular disease residency at East New York Diagnostic and Treatment Center in 2014 Dr. Gould’s areas of interest include glaucoma, retina, and anterior and posterior segment disease. She is a fellow of the American Academy of Optometry, a diplomate of the American Board of Optometry and a member of the Optometric Glaucoma Society.

Danica Marrelli, OD, FAAO, Dipl AAO & ABO, is a Clinical Professor at the University of Houston College of Optometry, where she is the Assistant Dean of Clinical Education and director of the Medical Eye Service. After receiving her Doctor of Optometry degree at the UHCO, Dr. Marrelli completed a residency in hospital-based optometry at the Baltimore VA Medical Center. She is currently . In the classroom, Dr. Marrelli teaches ocular pharmacology, glaucoma and case-based learning courses. Dr. Marrelli is a diplomate in the ocular disease (glaucoma) section of the American Academy of Optometry and serves as the secretary of the Optometric Glaucoma Society.

I. Paul Singh, MD, is the President of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He was a chief resident and completed his residency at Cook County Hospital – Division of Ophthalmology, and his internship at Michael Reese Hospital – Department of Medicine, both in Chicago, Illinois. He maintains a full-time research facility and is currently is involved in industry sponsored and independent research in glaucoma, cataract, ocular surface disease, and retina. He has a strong passion for new technology. He was the first surgeon in Wisconsin to perform many of the minimally invasive glaucoma surgeries (MIGS), such as the iStent, Cypass, Hydrus, and Kahook Dual Blade goniotomy.

Shalini Sood-Mendiratta, MD, is a Glaucoma specialist at Cole Eye Institute at the Cleveland Clinic Foundation. She trained at the University of Illinois Eye and Ear Infirmary for residency and completed her fellowship training at Emory Eye Center. Dr. Sood has been practicing for more than thirteen years and in addition to her clinical practice, she is involved with resident and fellowship education and training. Dr. Sood is excited about the surgical advancements being made in the field of glaucoma. She currently performs cataract surgeries including laser-assist and premium lenses, glaucoma lasers and surgeries, including a variety of MIGS procedures, trabeculectomy and glaucoma drainage implants.


Surgical Track

Daniel H. Chang, MD, is a board-certified ophthalmologist who graduated with honors from the California Institute of Technology and received his medical degree from Duke University. Dr. Chang completed his residency at Emory University and a fellowship in cornea and refractive surgery at Minnesota Eye Consultants. Dr. Chang is a regular researcher, speaker, and author on topics of diagnostics, refractive cataract surgery, and advanced intraocular lenses. His professional interests include the treatment of refractive error and presbyopia through improvements in biometry, IOL optics, and lens positioning. Dr. Chang founded Advanced Center for Eyecare (ACE) and ACE Global, non-profit organizations dedicated to bringing medical and surgical eye care to needy patients domestically and internationally.

Sumitra Khandelwal, MD, is Assistant Professor of Ophthalmology at Baylor College of Medicine, Cullen Eye Institute and also serves as Medical Director for the Lions Eye Bank of Texas. Her clinical interests include cornea, cataract and refractive surgery. She has written several publications and spoken at national meetings about optimizing outcomes in cornea and cataract surgery. She is associate editor of Cornea Cross-Linking, 2nd edition a comprehensive overview of the treatment options for keratoconus and ectasia after LASIK. Dr Khandelwal sees patients at Alkek Eye Center in the medical center as well as at Space Center Eye in Clear Lake.

Ashleigh Levison, MD, specializes in medical and surgical retina as well as uveitis, practicing at Colorado Retina Associates in Denver, Colorado. She primarily cares for patients with macular degeneration, diabetic eye disease, vascular occlusions, vitreomacular interface disorders, retinal detachments, and inflammatory eye disease, also known as uveitis. She has served on multiple advisory boards, published cutting-edge research, and is often found traveling as a keynote lecturer at renowned scientific meetings.

Julie Schallhorn, MD, MS, is Associate Professor of Ophthalmology at UCSF. Dr. Schallhorn received her undergraduate degree in Chemical Engineering from UCLA, and her Master’s degree in Bioengineering from UCSD. She then completed medical training at the University of Southern California Keck School of Medicine, and her ophthalmology residency at UCSF. She currently sits on the Ophthalmic Technology Assessment Committee for Refractive Surgery for the American Academy of Ophthalmology and the Young Eye Surgeons Committee for the American Society of Cataract and Refractive Surgeons.

Elizabeth Yeu, MD
, earned her medical degree through an accelerated and combined undergraduate/medical school program at the University of Florida College of Medicine. She completed her Ophthalmology residency at Rush University Medical Center in Chicago, where she served as Chief Resident. Dr. Yeu continued to the Cullen Eye Institute, Baylor College of Medicine to complete a Fellowship in Cornea, Anterior Segment and Refractive Surgery, where she served as an Assistant Professor after her fellowship training. Dr. Yeu joined Virginia Eye Consultants in 2013, now a partner since 2014, and also continues her commitment to residency training in Ophthalmology as an Assistant Professor at the Eastern Virginia Medical School. She is the Medical Director of the Virginia Surgery Center and sits on the Board of Directors for the Virginia Eye Foundation.

The statements of the healthcare professionals taking part in this program reflect only their personal opinions and do not necessarily reflect the opinions of any institution with which they are affiliated. The healthcare professionals participating in this program have a contractual or other financial relationship with Carl Zeiss Meditec, Inc. and have received financial support.